- Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
- Genomic epidemiology of SARS-CoV-2 in large university hospital cohort: the UnCoVER-Brazil project
- Integrating Methylome and Transcriptome Signatures Expands the Molecular Classification of the Pituitary Tumors
- Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition
- Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries
- Telomere length and Wnt/β-catenin pathway in adamantinomatous craniopharyngiomas
- Extracellular Vesicles and Interleukins: Novel Frontiers in Diagnostic and Therapeutic for Cancer
- Immune Checkpoint Inhibitors in Tumors Harboring Homologous Recombination Deficiency: Challenges in Attaining Efficacy
- Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors
- Altered regulation of DPF3, a member of the SWI/SNF complexes, underlies the 14q24 renal cancer susceptibility locus
- Lack of transgenerational effects of ionizing radiation exposure from the Chernobyl accident
- Cell-free DNA promotes malignant transformation in non-tumor cells
- Predicting immunotherapy response through genomics
- Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma
- Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits
- Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma
- Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer
- Sex specific associations in genome wide association analysis of renal cell carcinoma
- Sex-Related Effect on Immunotherapy Response: Implications and Opportunities
- Detectible mosaic truncating PPM1D mutations, age and breast cancer risk
- Precision oncology: as much expectations as limitations
- The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study
- Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]
- Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and Prognosis of Adamantinomatous Craniopharyngiomas
- Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia
- Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma
- Genome-wide association study identifies multiple risk loci for renal cell carcinoma
- Landscape of Combination Immunotherapy and Targeted Therapy to Improve Cancer Management
- HPA axis dysregulation, NR3C1 polymorphisms and glucocorticoid receptor isoforms imbalance in metabolic syndrome
- Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41
- Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses
- Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas
- Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy
- Glucocorticoid resistance in dialysis patients reduces long-term graft survival after kidney transplantation
- Altered expression of noncanonical Wnt pathway genes in paediatric and adult adrenocortical tumours
- ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas
- Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors
- Resistance to octreotide LAR in acromegalic patients with high SSTR2 expression: analysis of AIP expression
- SAGE analysis highlights the putative role of underexpression of ribosomal proteins in GH-secreting pituitary adenomas
- AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression
- Childhood adrenocortical tumors: from a clinical to a molecular approach
- CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas